Alpha Family Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Hold
4,160
0.12% 157
2025
Q4
$224K Buy
+4,160
New +$200K 0.1% 176
2025
Q2
Sell
-12,920
Closed -$788K 190
2025
Q1
$788K Hold
12,920
0.46% 48
2024
Q4
$731K Sell
12,920
-5,840
-31% -$326K 0.41% 41
2024
Q3
$971K Buy
18,760
+9,430
+101% +$442K 0.54% 32
2024
Q2
$387K Buy
+9,330
New +$417K 0.23% 75
2024
Q1
Sell
-7,110
Closed -$365K 157
2023
Q4
$365K Buy
+7,110
New +$373K 0.25% 78
2023
Q1
Sell
-4,330
Closed -$312K 124
2022
Q4
$312K Buy
+4,330
New +$326K 0.28% 76

Other funds holding BMY

Alpha Family Trust's BMY Position: Q1 2026 in Review

Alpha Family Trust held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 4,160 shares worth $252K. The position accounts for 0.12% of the portfolio, ranked #157.

Alpha Family Trust first reported a position in BMY in Q4 2022 and has held it in 8 quarters since. The position peaked at $971K in Q3 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Alpha Family Trust held 4,160 shares of Bristol-Myers Squibb worth $252K as of Q1 2026.
  • Alpha Family Trust left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.12% of Alpha Family Trust's portfolio in Q1 2026, its #157 holding.
  • Alpha Family Trust first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 8 quarters since.
  • Alpha Family Trust's Bristol-Myers Squibb position peaked at $971K in Q3 2024.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Alpha Family Trust's 13F filing for Q1 2026, filed 13 May 2026.